Effective and compelling positioning, pricing, promotion and placement are the basics of successful marketing and the foundation required for successful sales. Defining strategy is step one, successful implementation, step two, and an honest assessment of results—the step some find most challenging—is step three. This is as true in the oncology market as it is for all therapeutic areas.
In today's increasingly complex and competitive cancer market, brand teams are under intense pressure to set and implement strategies which optimize the life time value of new and existing oncology drugs. Doing so requires timely access to real in-market performance, an objective assessment of the relationships between effort and results (read: cause and effect), and informed insights and recommendations regarding strategic and tactical alternatives.
IMS Health's clinically-rich and analytically-deep cross-functional teams integrate market intelligence with industry experience and provide accurate assessments and sound recommendations to oncology brand teams across the continuum of sales and marketing decisions. Spanning market conditioning entry strategy, brand positioning, key opinion leader engagement, PR/media tactics and promotional channel choices and charges, IMS provides customers in the oncology market with the global information assets, analytics, and consulting expertise needed to make decisions with confidence.
Read more about our specific capabilities fueling marketing and sales effectiveness using the links below.